Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chromium picolinate in metabolic dysfunction-associated steatotic liver disease
IRCT20250222064808N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of chromium picolinate in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Tehran University of Medical Sciences. Started Jun 2025; status: completed.
02
Drugs
chromium picolinate
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on IRCT20250222064808N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250222064808N1.